Apolipoprotein E gene polymorphism in renal transplant recipients: Effects on lipid metabolism, atherosclerosis and allograft function

Clinical Transplantation

Volumn 18, Issue 3, 2004, Pages 288-294

  Kahraman, Serkan ^a   Kiykim, Ahmet Alper ^a   Altun, Bülent ^a   Gençtoy, Gültekin ^a   Arici, Mustafa ^a   Gulsun, Meltem ^a   Erdem, Yunus ^a   Yasavul, Unal ^a   Turgan, Çetin ^a   Çaǧlar, Şali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Apolipoprotein E; Atherosclerosis; Renal transplantation

Indexed keywords

ACUTE PHASE PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; CREATININE; GENOMIC DNA; ISOPROTEIN; LOW DENSITY LIPOPROTEIN; RESTRICTION ENDONUCLEASE; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CAROTID ARTERY; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; GLOMERULOSCLEROSIS; HETEROZYGOTE; HUMAN; HYPERLIPIDEMIA; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; RESTRICTION MAPPING; RISK FACTOR;

ADULT; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 2942613317     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00162.x     Document Type: Article

References (34)

1. Raine AEG, Ledingham JGG. Cardiovascular complications after renal transplantation. In: Morris PJ ed. Kidney Transplantation, 2nd edn. London: Grune & Stratton, 1984: 469.
2. Disney APS. 12th Rep of the Australia and New Zealand Combined Dialysis and Transplant Registry (ANZDATA) 1989: 28-29 and 123.
3. Barbagallo CM, Averna MR, Sparacino V et al. Lp(a) levels in end stage renal failure and renal transplantation. Nephron 1993: 64: 560.
4. Roussos L, Floren CH, Carlson J, Svenson P, Wallmark A, Ekberg H. Increased prevalence of apolipoprotein E3/E4 genotype among Swedish renal transplant recipients. Nephron 1999: 83: 25.
5. Mahley RW, Innerarity TL, Stanley C et al. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984: 25: 1277.
6. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988: 8: 1.
7. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988: 240: 622.
8. Demant TD, Bedford C, Pachard CJ, Shepherd J. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. J Clin Invest 1991: 88: 1490.
9. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary artery heart disease. Framingham off-spring study. JAMA 1994: 272: 1666.
10. Diamond JR. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 1994: 45: 125.
11. Dimeny E, Tufveson G, Larsson E et al. The influences of pretransplant lipoprotein abnormalities on early results of renal transplant. Eur J Clin Invest 1993: 23: 572.
12. Friedewald WT, Levy RJ, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972: 18: 499.
13. Massy ZA, Mamzer-Bruneel MF, Chevalier A et al. Carotid atherosclerosis in renal transplant recipients. Nephrol Dial Transplant 1998: 13: 1792.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
15. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one stage PCR. Lancet 1991; 337: 1158.
16. Gülen A, Acartürk E, Eskandari G, Akpinar O et al. Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey. Clin Chim Acta 2001: 312: 191.
17. Brunner FP, Broyer M, Brynger H et al. Survival on renal replacement therapy: data from the EDTA Registry. Nephrol Dial Transplant 1988: 2: 109.
18. Ibels LS, Stewart JH, Mahoney JF, Sheil AGR. Deaths from occlusive arterial disease in renal allograft recipients. Br Med J 1974: 3: 552.
19. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986: 74: 1399.
20. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscl Thromb 1991: 11: 1245.
21. Rubba P, De Simone B, Postiglione A, Cortese C et al. Extracoronary atherosclerosis in familial hypercholesterolemia. Atherosclerosis 1988: 71: 205.
22. Jogestrand T, Fehrman-Ekholm I, Angelin B, Berglund L, Gabel H. Increased prevalence of atherosclerotic wall changes in patients with hyperlipidemia after renal transplantation. Jour of Int Med 1996: 239: 177.
23. Imura T, Kimura H, Gejyo F. Apolipoprotein E phenotypes in hemodialysis patients. Kidney Int 1999: 56(Suppl.): 245.
24. Oda H, Yorioka N, Ueda C, Kushihata S, Yamakido M. Apolipoprotein E polymorphism and renal disease. Kidney Int 1999: 56(Suppl.): 25.
25. Breslow JL. Familial disorders of high density lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, Vol. 2, 7th edn. New York: McGraw-Hill, 1995: 2031.
26. Paszty C, Maeda N, Verstuyfi J et al. Apolipoprotein A1 transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest 1994: 94: 899.
27. Ilveskoski E, Loimaala A, Mercuri MF, Lehtlmaki T et al. Apolipoprotein E polymorphism and carotid intima-media thickness in a random sample of middle aged men. Atherosclerosis 2000: 153: 147.
28. DeAndrade M, Thandi I, Brown S, Gotto A Jr et al. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet 1995: 56: 1379.
29. Guz G, Ozdemir N, Sezer S, Işiklar S et al. Effect of apolipoprotein E polymorphism on serum lipid, lipoprotein and atherosclerosis in hemodialysis patients. Am J Kidney Dis 2000: 36: 826.
30. Krolewski AS, Warram JH, Christlieb R. Hypercholesterolemia: a determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 1994: 45: 125.
31. Lam KSL, Cheng JKP, Janus ED, Pang RW. Cholesterol lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 1995: 38: 604.
32. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988: 84: 985.
33. Grone EF, Walli AK, Grone HJ, Miller B, Seidel D. The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 1994: 107: 1.
34. Capelli P, Evangelista M, Bonomini M, Palmieri PF, Albertazzi A. Lipids in the progression of chronic renal failure. Nephron 1992: 62: 31.